# Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using Metabolomics

> **NCT03964701** · — · UNKNOWN · sponsor: **Baxter (Hellas) Ltd** · enrollment: 18 (estimated)

## Conditions studied

- End Stage Renal Disease
- Dialysis

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT03964701
- **Lead sponsor:** Baxter (Hellas) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-22
- **Primary completion:** 2020-04-22
- **Final completion:** 2020-04-22
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03964701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03964701, "Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using Metabolomics". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03964701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*